Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -7.84x is 487% below its 5-year average of -1.34x, near the low end of its 5-year range (-7.84x–2.99x).
As of the fiscal period ended Thursday, August 31, 2023. 141.70% below its 12-month average of -3.24x.
Reported quarterly interest coverage; no daily interpolation. Q3 FY2023 (2023-08-31): -7.84x.
INTEREST COVERAGE RATIO
-7.84x
INTEREST COVERAGE RATIO AVG TTM
-3.24x
INTEREST COVERAGE RATIO AVG 3Y
-2.06x
INTEREST COVERAGE RATIO AVG 5Y
-1.34x
INTEREST COVERAGE RATIO AVG 10Y
-0.60x
INTEREST COVERAGE RATIO AVG 15Y
-0.45x
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-141.70%
CURRENT VS 3Y AVG
-279.76%
CURRENT VS 5Y AVG
-486.64%
CURRENT VS 10Y AVG
-1196.55%
CURRENT VS 15Y AVG
-1659.81%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-22.96%
vs the sector median at left
CAMP4 Therapeutics Corporation
Market Cap
$236.58M
Interest Coverage Ratio
-7.84x
TTM Avg
-3.24x
3Y Avg
-2.06x
5Y Avg
-1.34x
Market Cap
$236.39M
Interest Coverage Ratio
0.97x
TTM Avg
0.97x
3Y Avg
0.97x
5Y Avg
0.97x
Market Cap
$237.69M
Interest Coverage Ratio
-1.08x
TTM Avg
0.39x
3Y Avg
0.39x
5Y Avg
0.20x
Market Cap
$235.40M
Interest Coverage Ratio
N/A
TTM Avg
148.42x
3Y Avg
88.50x
5Y Avg
120.78x
Market Cap
$235.36M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$234.90M
Interest Coverage Ratio
N/A
TTM Avg
28.01x
3Y Avg
25.48x
5Y Avg
25.48x
Market Cap
$238.81M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$233.46M
Interest Coverage Ratio
-1280.37x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CAMP4 Therapeutics Corporation (CAMP) | $236.58M | -7.84x | -3.24x | -2.06x | -1.34x |
| Akebia Therapeutics, Inc. (AKBA)vs › | $236.39M | 0.97x | 0.97x | 0.97x | 0.97x |
| Invivyd, Inc. (IVVD)vs › | $237.22M | N/A | N/A | N/A | N/A |
| High Tide Inc. (HITI)vs › | $237.69M | -1.08x | 0.39x | 0.39x | 0.20x |
| Utah Medical Products, Inc. (UTMD)vs › | $235.40M | N/A | 148.42x | 88.50x | 120.78x |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $235.36M | N/A | N/A | N/A | N/A |
| SIGA Technologies, Inc. (SIGA)vs › | $234.90M | N/A | 28.01x | 25.48x | 25.48x |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $238.81M | N/A | N/A | N/A | N/A |
| InflaRx N.V. (IFRX)vs › | $233.46M | -1280.37x | N/A | N/A | N/A |
| Galectin Therapeutics Inc. (GALT)vs › | $242.02M | -2.74x | N/A | N/A | N/A |
Interest Coverage
-7.8x
Debt/Equity
N/A
Current Ratio
4.70
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2023-08-31 | -7.84x |
| 2023-05-31 | -1.42x |
| 2023-02-28 | -0.98x |
| 2022-11-30 | -2.33x |
| 2022-08-31 | -3.65x |
| 2022-05-31 | -6.09x |
| 2022-02-28 | -1.15x |
| 2021-11-30 | -1.71x |
| 2021-08-31 | -0.26x |
| 2021-05-31 | -0.32x |
| 2021-02-28 | -0.08x |
| 2020-11-30 | -5.16x |
| 2020-08-31 | -1.62x |
| 2020-05-31 | -2.43x |
| 2020-02-29 | -6.09x |
| 2019-11-30 | -0.80x |
| 2019-08-31 | -0.83x |
| 2019-05-31 | -1.22x |
| 2019-02-28 | 2.99x |
| 2018-11-30 | 0.12x |
| 2018-08-31 | 1.13x |
| 2018-05-31 | -0.22x |
| 2018-02-28 | 0.74x |
| 2017-11-30 | 1.64x |
| 2017-08-31 | 1.22x |
| 2017-05-31 | -0.53x |
| 2017-02-28 | -0.92x |
| 2016-11-30 | 0.72x |
| 2016-08-31 | 1.58x |
| 2016-05-31 | -0.84x |
| 2016-02-29 | 1.88x |
| 2015-11-30 | 3.82x |
| 2015-08-31 | 3.46x |
| 2015-05-31 | 11.36x |
| 2014-11-30 | 537.92x |
| 2014-08-31 | 1006.60x |
| 2014-05-31 | 45.58x |
| 2014-02-28 | 52.55x |
| 2013-11-30 | 90.03x |
| 2013-08-31 | 54.68x |
| 2013-05-31 | 23.58x |
| 2013-02-28 | 21.11x |
| 2012-11-30 | 33.43x |
| 2012-08-31 | 30.72x |
| 2012-05-31 | 66.89x |
| 2012-02-28 | 36.24x |
| 2011-11-26 | 26.76x |
| 2011-08-27 | 3.83x |
| 2011-05-28 | 2.37x |
| 2011-02-28 | 1.25x |
| 2010-11-27 | 0.39x |
| 2010-08-28 | -1.53x |
| 2010-05-29 | -5.66x |
| 2010-02-28 | -3.08x |
| 2009-11-28 | -10.05x |
| 2009-08-29 | -17.67x |
| 2009-05-30 | -17.02x |
